TBK1, a downstream effector of the miR-200c-driven pathway, facilitates EMT and invasiveness of lung cancer cells by controlling synthase kinase-3β (GSK-3β) phosphorylation and zinc finger E-box-binding homeobox 1 (ZEB1) expression [52,53]. Here, ZEB1 is linked to lung carcinoma.